AAA is a GPR75 antagonist that elevates basal receptor levels and blocks 20-HETE-mediated GPR75 downregulation in PC3 cells. It inhibits 20-HETE-induced signaling through EGFR, NF-κB, and Akt, thereby reducing cell migration, making it a useful tool for studying oncogenic pathways in prostate cancer research.